Single‐cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation
Liver International · 2024-09 · 44 (9) · 2382-2395
DOI: 10.1111/liv.15963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 07.06.2024. Verfasst von Mathias Declercq und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Development and Regeneration, Woman and Child Unit, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Cystic Fibrosis, Single-Cell Analysis, Endothelial Cells, Sequence Analysis, RNA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: King Baudouin Foundation, Mucovereniging, UZ Leuven.
Abstract (Originalsprache)
Background & Aims Cystic fibrosis (CF) is considered a multisystemic disorder in which CF‐associated liver disease (CFLD) is the third most common cause of mortality. Currently, no effective treatment is available for CFLD because its pathophysiology is still unclear. Interestingly, CFLD exhibits identical vascular characteristics as non‐cirrhotic portal hypertension, recently classified as porto‐sinusoidal vascular disorders (PSVD).
Methods
Since endothelial cells (ECs) are an important component in PSVD, we performed single‐cell RNA sequencing (scRNA‐seq) on four explant livers from CFLD patients to identify differential endothelial characteristics which could contribute to the disease. We comprehensively characterized the endothelial compartment and compared it with publicly available scRNA‐seq datasets from cirrhotic and healthy livers. Key gene signatures were validated ex vivo on patient tissues.
Results
We found that ECs from CF liver explants are more closely related to healthy than cirrhotic patients. In CF patients we also discovered a distinct population of liver sinusoidal ECs—coined CF LSECs—upregulating genes involved in the complement cascade and coagulation. Finally, our immunostainings further validated the predominant periportal location of CF LSECs.
Conclusions
Our work showed novel aspects of human liver ECs at the single‐cell level thereby supporting endothelial involvement in CFLD, and reinforcing the hypothesis that ECs could be a driver of PSVD. Therefore, considering the vascular compartment in CF and CFLD may help developing new therapeutic approaches for these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Development and Regeneration, Woman and Child Unit, KU Leuven, Leuven, Belgium.
- Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, Leuven, Belgium.
- Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.
- Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
- The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
- Department of Biotechnology, Indian Institute of Technology, Hyderabad, Telangana, India.
ORCID-Profile: Lucas Treps, Nadine V Conchinha, Tania Roskams
Förderung
- King Baudouin Foundation
- Mucovereniging
- UZ Leuven
- I-SITE NExT Junior Talent
- European Regional Development Fund (FEDER)
- Vaincre La Mucoviscidose and Grégory Lemarchal Associations
- Methusalem funding (Flemish government)
- Research Foundation Flanders (FWO-Vlaanderen)
Zitieren
APA
Declercq, M., Treps, L., Geldhof, V., Conchinha, N. V., de Rooij, L. P. M. H., Subramanian, A., Feyeux, M., Cotinat, M., Boeckx, B., Vinckier, S., Dupont, L., Vermeulen, F., Boon, M., Proesmans, M., Libbrecht, L., Pirenne, J., Monbaliu, D., Jochmans, I., Dewerchin, M., …, & Witters, P. (2024). Single‐cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation. Liver International, 44(9), 2382-2395. https://doi.org/10.1111/liv.15963
Vancouver
Declercq M, Treps L, Geldhof V, Conchinha NV, de Rooij LPMH, Subramanian A, et al. Single‐cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation. Liver International. 2024;44(9):2382-2395. doi:10.1111/liv.15963
BibTeX
@article{Declercq2024,
author = {Declercq, Mathias and Treps, Lucas and Geldhof, Vincent and Conchinha, Nadine V and de Rooij, Laura P M H and Subramanian, Abhishek and Feyeux, Magalie and Cotinat, Marine and Boeckx, Bram and Vinckier, Stefan and Dupont, Lieven and Vermeulen, Francois and Boon, Mieke and Proesmans, Marijke and Libbrecht, Louis and Pirenne, Jacques and Monbaliu, Diethard and Jochmans, Ina and Dewerchin, Mieke and Eelen, Guy and Roskams, Tania and Verleden, Stijn and Lambrechts, Diether and Carmeliet, Peter and Witters, Peter},
title = {Single‐cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation},
journal = {Liver International},
year = {2024},
volume = {44},
number = {9},
pages = {2382--2395},
doi = {10.1111/liv.15963}
}
EUVIMED